Thomas Daniel

Directeur/Membre du Conseil chez GOSSAMER BIO, INC. Fortune : 5 866 $ au 30/09/2026

Profil

Dr. Thomas O.
Daniel, MD, is an Independent Director at Aspen Neuroscience, Inc., an Independent Director at Gossamer Bio, Inc., a Chairman at Locanabio, Inc., a Chairman at Gate Therapeutics, a Chairman at Life Science Cares San Diego LLC, a Chairman at Trotana, Inc. and a Chairman-Overseers Board at The Scripps Research Institute.
He is on the Board of Directors at Mozart Therapeutics, Inc., Aspen Neuroscience, Inc., Gossamer Bio, Inc., The Reed Institute, FerruMax Pharmaceuticals, Inc. and Lupus Research Alliance, Inc. Dr. Daniel was previously employed as an Independent Director by Larimar Therapeutics, Inc., an Independent Director by Vir Biotechnology, Inc., a Venture Partner by ARCH Venture Partners LLC, an Independent Director by Magenta Therapeutics, Inc., an Executive Director by Catalyst Advisors LP, an Independent Director by Zafgen, Inc., an Independent Director by Juno Therapeutics, Inc., a Chairman-Research Division by Celgene Corp., a Vice President-Research by Amgen, Inc., a Senior Vice President-Discovery Research by Immunex Corp., a Chief Scientific Officer & Director by Ambrx, Inc., and a Professor by Vanderbilt University.
He also served on the board at ImmusanT, Inc., Vividion Therapeutics, Inc., Epizyme, Inc., Abide Therapeutics, Inc., Alliance for Lupus Research, Epizyme, Inc., Pharmaceutical Research & Manufacturers of America, PharmAkea, Inc., Sana Biotechnology, Inc. and Vanderbilt Vascular Biology Center.
He received his undergraduate degree from Southern Methodist University, a doctorate degree from The University of Texas at Austin and a doctorate degree from The University of Texas Southwestern Medical Center.

Détentions connues dans des sociétés publiques

Société	Date	Nombre d'actions	Valorisation	Date de valorisation
GOSSAMER BIO, INC. 0,01 %	23/09/2026	495 ( 0,01 % )	5 866 $	30/09/2026

Postes actifs de Thomas Daniel

Sociétés	Poste	Début
GOSSAMER BIO, INC.	Directeur/Membre du Conseil	01/01/2018
Lupus Research Alliance, Inc.	Directeur/Membre du Conseil	-
Aspen Neuroscience, Inc.	Directeur/Membre du Conseil	01/03/2020
Mozart Therapeutics, Inc.	Directeur/Membre du Conseil	01/06/2020
Trotana, Inc.	Président	-
The Reed Institute	Directeur/Membre du Conseil	01/03/2017
Locanabio, Inc.	Président	-
The Scripps Research Institute	Corporate Officer/Principal	-
FerruMax Pharmaceuticals, Inc.	Directeur/Membre du Conseil	-

Anciens postes connus de Thomas Daniel

Sociétés	Poste	Fin
░░░░░░░ ░░░░░░░░░░░░░ ░░░░	░░░░░░░░░░░░░░░░ ░░ ░░░░░░░	░░░░░░░░░░
░░░░ ░░░░░░░ ░░░░░░░░ ░░░	░░░░░░░░ ░░ ░░░░░░░░░░░░░░░░░░░░░░	░░░░░░░░░░
░░░░░░░ ░░░░░░░░░░░░░ ░░░░	░░░░░░░░░░░░░░░░ ░░ ░░░░░░░	░░░░░░░░░░
░░░░░░░░░ ░░░░	░░░░░░░░░░░░░░░░ ░░ ░░░░░░░	░░░░░░░░░░
░░░░ ░░░░░░░░░░░░ ░░░	░░░░░░░░░░░░░░░░ ░░ ░░░░░░░	░░░░░░░░░░